Embriz-L Injection
Prescription Required
Product introduction
Embriz-L Injection is a medicine used in the treatment of gastrointestinal problems like functional dyspepsia, nausea, vomiting, and diabetic gastroparesis. It improves food movement and treats disorders of the stomach and intestines.
Embriz-L Injection is used to treat schizophrenia and Parkinson's disease (a disorder of the nervous system that causes difficulties with movement and balance) in whom other medicines have not worked.
Embriz-L Injection is used to treat schizophrenia and Parkinson's disease (a disorder of the nervous system that causes difficulties with movement and balance) in whom other medicines have not worked.
Uses of Embriz-L Injection
Benefits of Embriz-L Injection
In Treatment of Functional dyspepsia
Functional dyspepsia is another term for indigestion that is not associated with a specific cause. It may cause symptoms such as an early feeling of fullness after eating, stomach pain or discomfort, nausea, and bloating. Embriz-L Injection helps treat these symptoms by increasing the rate of stomach emptying. Some simple lifestyle changes can help stop or reduce these symptoms. Think about what foods trigger your symptoms and try to avoid them; eat smaller, more frequent meals; try to lose weight if you are overweight and try to find ways to relax. Do not eat within 3 to 4 hours of going to bed.
In Treatment of Nausea
Embriz-L Injection blocks the action of chemicals in the body that can make you feel or be sick. This medicine helps you feel better and at ease. It is given as an injection by a doctor and you should follow the doctor’s instructions carefully to get the most benefit from this medicine.
In Treatment of Diabetic gastroparesis (diabetic nerve disease affecting stomach)
Diabetic gastroparesis is a condition in diabetic patients in which the stomach cannot empty digested food normally. Symptoms may include heartburn, nausea, vomiting, and feeling full faster than normal while eating. Embriz-L Injection helps relieve these symptoms and restores normal movement of food in the stomach and intestines. This improves your digestion and makes you feel better.
Side effects of Embriz-L Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Embriz-L
- Menstrual disorder
- Breast enlargement in male
- Increased libido
- Increased prolactin level in blood
- Extrapyramidal symptoms
- Weight gain
- Akathisia (inability to stay still)
- Increased liver enzymes
- Constipation
- Insomnia (difficulty in sleeping)
- Sedation
- Maculopapular rash
How to use Embriz-L Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Embriz-L Injection works
Embriz-L Injection is an atypical antipsychotic. It works by increasing the release of acetylcholine (a chemical messenger). This increases the movement of stomach and intestines, and prevents reflux (acid going up to the food pipe) as well as nausea or vomiting. Since it modulates the motor function of the gastrointestinal tract, it also improves delayed gastric emptying.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with Embriz-L Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Embriz-L Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Embriz-L Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Embriz-L Injection may cause side effects which could affect your ability to drive.
Embriz-L Injection may cause drowsiness, so do not drive or do anything that requires mental focus until you know how this medicine affects you.
Embriz-L Injection may cause drowsiness, so do not drive or do anything that requires mental focus until you know how this medicine affects you.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Embriz-L Injection in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Embriz-L Injection in patients with liver disease. Please consult your doctor.
What if you forget to take Embriz-L Injection?
If you miss a dose of Embriz-L Injection, please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Embriz-L Injection
₹99.0/Injection
Levazeo 12.5mg Injection
Torrent Pharmaceuticals Ltd
₹54/injection
45% cheaper
Macsulpride 12.5mg Injection
Macro Labs Pvt Ltd
₹70/injection
29% cheaper
Lempride 12.5mg Injection
Mits Healthcare Pvt Ltd
₹70/injection
29% cheaper
Losrest 12.5mg Injection
Arlak Biotech Pvt Ltd
₹32/injection
68% cheaper
Kalpride 12.5mg Injection
Kalmia Healthcare
₹70/injection
29% cheaper
Fact Box
Chemical Class
Benzenesulfonamide Derivative
Habit Forming
No
Therapeutic Class
NEURO CNS
Action Class
Atypical Antipsychotics
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Lozano R, Concha MP, Montealegre A, et al. Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia. Ther Clin Risk Manag. 2007;3(1):149-55. [Accessed 29 Jan. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 25 Mar. 2019] (online) Available from:
Marketer details
Name: Novogen Captab
Address: SCO, No. 178, 1st Floor, Sector 39 D, Chandigarh-160036, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹99
Inclusive of all taxes
2.0 ml in 1 vial
SOLD OUT
Notify me